Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02604667 · ClinicalTrials.gov registry record
Mechanisms of Ischemic Stroke in Cancer Patients
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 150
- Enrollment target
NCT02604667: Completed study, sponsored by Weill Medical College of Cornell University.
NCT02604667 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02604667 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the causes of stroke in people with cancer. Active cancer increases the risk of stroke. The investigators do not know exactly why this occurs but one possible reason is that people with cancer may have thicker blood than people without cancer. Thick blood can sometimes cause blood clots to form in the heart, which can then travel to the brain and cause stroke. This study is being done to help figure out why this and other causes of stroke occur in people with cancer. The investigators expect that information from this study will help doctors to more effectively prevent and treat stroke in individuals with cancer.
Primary Outcome
Hematological testing will consist of a single peripheral blood draw at 96 hours (+/-24 hours). Several factors will be evaluated, including markers of coagulation (thrombin-antithrombin complex, D-dimer), platelet function (P-selectin), and endothelial integrity (sICAM-1, sVCAM-1, thrombomodulin).
Interventions
- OTHER Blood tests
- OTHER Transcranial Doppler Microemboli Detection Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2016-04-08 |
| Est. Completion | 2020-09-01 |
What the finished NCT02604667 record still lists
NCT02604667 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Blood tests is the first listed.
NCT02604667 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02604667 about?
NCT02604667 is a clinical study titled "Mechanisms of Ischemic Stroke in Cancer Patients". The purpose of this study is to better understand the causes of stroke in people with cancer. Active cancer increases the risk of stroke. The investigators do not know exactly why this occurs but one possible reason is that people with cancer may have thicker blood than people without cancer. Thick ...
What is the current status of trial NCT02604667?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2016-04-08. Estimated completion is 2020-09-01.
What interventions are being tested in trial NCT02604667?
The interventions under investigation include: Blood tests (OTHER), Transcranial Doppler Microemboli Detection Study (OTHER).
Who is sponsoring clinical trial NCT02604667?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI